Randomized Study Comparing Induction Chemotherapy With Docetaxel, Cisplatin, 5FU [fluorouracil] Versus Cisplatin, 5 FU in Patients With T3 and T4 Larynx and Hypopharynx Carcinoma

Trial Profile

Randomized Study Comparing Induction Chemotherapy With Docetaxel, Cisplatin, 5FU [fluorouracil] Versus Cisplatin, 5 FU in Patients With T3 and T4 Larynx and Hypopharynx Carcinoma

Completed
Phase of Trial: Phase III

Latest Information Update: 28 Oct 2015

At a glance

  • Drugs Docetaxel (Primary) ; Cisplatin; Fluorouracil
  • Indications Head and neck cancer; Laryngeal cancer
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 28 Oct 2015 Results of a long term follow up published in the Journal of the National Cancer Institute
    • 02 Jun 2015 Results of long term follow up (5 and 10 years) presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
    • 12 Oct 2009 Long-term quality-of-life data have been presented at the 15th European Cancer Conference and the 34th Congress of the European Society for Medical Oncology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top